(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide-D4;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide-D4; BIBW 2992-D4
Afatinib-d4 is a fully characterized chemical compound used as a reference standard of API Lumacaftor. The standard offered is compliant with regulatory guidelines. Afatinib-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
![Picture of 4-[(4-Chloro-3-fluorophenyl)amino]-6-nitroquinazolin-7-ol](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-A01483.jpg?size=256 "Show details for 4-[(4-Chloro-3-fluorophenyl)amino]-6-nitroquinazolin-7-ol")
4-(3-Chloro-4-fluorophenylamino)-7-fluoro-6-nitroquinazoline
M.F.
M.W. 336.69
CAT# AR-A01482
CAS# 162012-67-1
